ESWI 6th Influenza Conference, Riga, 10-13 September 2017

2016 08 25 Written by Vaccines Europe

The European Scientific Working group on Influenza (ESWI) is hosting the sixth edition of its ESWI Influenza Conferences in Riga, Latvia, on 10–13 September 2017. Over the past years, the ESWI Influenza Conferences have grown into the largest European scientific conferences entirely dedicated to influenza. Read more…

The EU Vaccine Industry in Figures

2016 07 13 Written by Vaccines Europe

Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region. Click here to access the infographic.

Council Conclusions on one health approach to combat AMR

2016 06 22 Written by Vaccines Europe

Vaccines Europe welcomes the EU Health Council adoption of the Council Conclusions on the next steps under a one health approach to combat antimicrobial resistance. Vaccines Europe believes that a holistic approach that takes into account alternative approaches which can reduce the use of antibiotics should be considered as part of a long term strategy to combat this global public health issue. The Council Conclusions call upon the Member States to “encourage the use of alternative treatment and prevention options including vaccines and the development and use of affordable diagnostics tests in human and veterinary medicine“, which is in line with recent evidence that suggests that antibiotic use can decrease in association with the initiation of immunisation programmes or increased uptake of available vaccines. The Vaccines Europe members are committed to this global health issue by investing in the development of vaccines that target resistant bacteria that causes healthcare associated infections, such as Staphylococcus aureus and Clostridium difficile which would play a crucial role in tackling drug resistance.

Find here a draft Vaccines Europe paper on the Role of vaccination in reducing antimicrobial resistance.

See all News